Idiopathic pulmonary fibrosis (IPF) is a severe lung disease that can be devastating to patients and their families. This progressive, irreversible disease causes scarring, organ damage, and reduced lung function.
If you have IPF, GALACTIC-1 needs your help studying an investigational drug to find out if it’s safe and effective at reducing the progression and symptoms of IPF.
You may qualify for this study if:
- You are between 40 and 90 years of age
- You have been diagnosed with IPF
All qualified participants will receive all study-related procedures and the investigational drug at no cost. Click the button below to take a short survey to find out if you qualify to take part in GALACTIC-1.